Dover NH

Jeffrey Brower, MD, PhD

Dover, Manchester | Radiation Treatment & Oncology

PubMed

Jeffrey Brower received his Bachelor of Science degree in Microbiology and Cell Science with a minor in Chemistry from the University of Florida. He then went on to earn his Ph.D. in Molecular Biology, during which time his research led to the discovery of a novel gene responsible for cellular respiration and energy metabolism. During his Ph.D. research, he was awarded the Alumni Fellowship and Medical Guild award for his work in molecular biology. Following the completion of his Ph.D., Dr. Brower matriculated to medical school at the University of Florida, graduating with research honors in 2012.

Dr. Brower completed his training in radiation oncology at the University of Wisconsin, serving as chief resident from 2016 to 2017. During residency, he gained extensive experience in the most current radiation therapy techniques, including intensity modulated radiotherapy (IMRT), Tomotherapy, image-guided radiotherapy, and stereotactic radiotherapy as well as the utilization of MRI-guided radiotherapy. In addition, Dr. Brower received comprehensive training in the utilization of brachytherapy to treat gynecologic malignancies. As a resident, Dr. Brower also participated in clinical research, publishing over 25 peer reviewed manuscripts and presenting his work at national conferences. Dr. Brower has published manuscripts on esophageal, lung, brain, head and neck, prostate, liver, skin and gynecologic cancers as well as brain metastases. After the completion of his training, Dr. Brower joined Radiation Oncology Associates in 2017. He currently serves as Gynecological Editor for Radoncquestions.com, an international online learning resource for radiation oncology physicians and trainees. Dr. Brower also is an active peer reviewer for many journals with the field of radiation oncology and continues to participate in resident education.

“It is a great privilege to care for the patients of New England. Community medicine provides me the opportunity to focus on improving the standards of patient care and ensuring that the highest quality therapy is available to patients closer to home.”

Bryan Rowe, MD

Concord | Radiation Treatment & Oncology

PubMed

Bryan Rowe studied biology at Wesleyan University, where he received his Bachelor of Arts with honors in 2000. He graduated from the University of Connecticut School of Medicine in 2007 and was granted the Excellence in Medical Studies award.
After completing his internship at Saint Vincent’s Medical Center in 2008, Dr. Rowe trained in radiation oncology at Yale New Haven Hospital, where he served as chief resident from 2011 to 2012. During residency, he gained extensive experience in the most current radiation therapy techniques, including intensity modulated radiotherapy (IMRT), image-guided radiotherapy (IGRT), stereotactic radiotherapy, and brachytherapy. Dr. Rowe also participated in a variety of research projects and published multiple articles on breast cancer and the use of stereotactic radiotherapy for lung cancer. He spent a month at the Mayo Clinic focusing on head and neck cancer and also received specialized training in prostate seed implantation at the Seattle Prostate Institute and Mount Sinai Hospital in New York City. Dr. Rowe joined Radiation Oncology Associates in 2012.

“I feel it is a great privilege to help patients and their families face the challenges of a cancer diagnosis. As part of a multidisciplinary team, I strive to provide the highest quality, individualized cancer care for patients in a comfortable, community setting.”

H. Andy Singh, MD

Dover, Portsmouth | Radiation Treatment & Oncology

View Dr. Singh’s Publications Below

Andy Singh received his Bachelor of Science degree in genetics from the University of California, Berkeley, in 1991 with honors. In 1995, he received his medical degree from University of Chicago Pritzker School of Medicine. During medical school, he was active in research for which he won several awards.

Dr. Singh completed an internship in internal medicine at Mount Auburn Hospital in Cambridge, MA. He continued his training in radiation oncology at Memorial Sloan-Kettering Cancer Center, where he was named Chief Resident for 1999-2000. During residency, Dr. Singh developed expertise in three dimensional (3D) conformal radiation therapy, intensity modulated radiation therapy (IMRT) and brachytherapy. After finishing his training, Dr. Singh joined Radiation Oncology Associates in 2000.

“I enjoy practicing medicine in this wonderful community,” Dr. Singh said. “Being in a small community allows me more time to interact with my patients and build lasting relationships with them and their families. The medical community in this area is thriving and I am proud to be a part of a team that delivers excellent care to patients in a comfortable setting.”

Andrea B. McKee, MD

Burlington, Peabody | Radiation Treatment & Oncology

PubMed

Andrea McKee received her Bachelor of Arts degree in biology in 1992 from the University of Pennsylvania with honors. She graduated from Columbia University College of Physicians and Surgeons in 1996. During college and medical school, she participated in laboratory and clinical research prior to continuing with her clinical training.

Dr. McKee stayed in New York City for her internship in internal medicine at Lenox Hill Hospital. She continued her training in radiation oncology at Memorial Sloan-Kettering Cancer Center, where she was named Chief Resident for 2000-2001.

During residency, Dr. McKee researched clinical outcomes in patients with tumors of the prostate, uterus, cervix, and musculoskeletal system. She developed expertise in intensity modulated radiation therapy (IMRT), high dose rate (HDR) brachytherapy and stereotactic radiosurgery. After finishing her training at Memorial Sloan-Kettering Cancer Center, Dr. McKee joined Radiation Oncology Associates in 2001.

Dr. McKee helped establish an HDR brachytherapy program in southern New Hampshire in 2004. With a team of neurosurgeons, oncologists, physicists, radiation therapists and oncology nurses, she developed a stereotactic radiotherapy program at the Elliot Hospital where she served as the medical director and co-director of the Elliot Radiosurgery Center. She now serves as the Chair of the Department of Radiation Oncology at Lahey Clinic in Burlington and Peabody.

“I became a radiation oncologist in order to practice medicine in an area that challenged me both emotionally and intellectually. The technological and therapeutic advances in radiation and medical oncology seen over the past few years have led to impressive and meaningful improvements in overall survival and quality of life for our patients. It is an exciting time for those of us who share in the privilege of caring for patients with cancer.

Jeffrey Lemons, MD, MS

Dover, Peabody, Portsmouth | Radiation Treatment & Oncology

PubMed

Jeff Lemons earned his Bachelor of Science degree from the University of Michigan in Ann Arbor, MI with a major in Cellular, Molecular, and Developmental Biology and a minor in Spanish. After finishing at Michigan, he was selected for the Intramural Research Training Award through the NIH and participated in a year-long research program at the NIDDK in Bethesda, MD. Afterwards, he matriculated into medical school at Temple University School of Medicine in Philadelphia, PA and graduated in 2013 as a member of the Alpha Omega Alpha Honor Society.

After medical school, Dr. Lemons completed internship at Crozer Chester Medical Center in Upland, PA followed by radiation oncology residency at the University of Chicago where he served as Chief Resident in his final year. During his training, he performed clinical research focusing on combining stereotactic body radiotherapy (SBRT) and immunotherapies as well as the utilization of radiation for oligometastases. Dr. Lemons has presented research at national meetings, published in peer-reviewed journals, and authored and managed clinical trials. To expand the scope of his training, he completed externships at the Northwestern Medicine Chicago Proton Center and The Royal Marsden Hospital in London, England. He attended the ASCO/AACR Methods in Clinical Cancer Research Workshop and earned a Master of Science through the Department of Public Health Sciences while at the University of Chicago.

Dr. Lemons joined Radiation Oncology Associates in 2018 after completing his training. He finds great satisfaction working with a team to provide high-quality and individualized care for his patients and help guide them through a difficult time in their lives.

Arul Mahadevan, MD

Dover, Portsmouth | Radiation Treatment & Oncology

PubMed

Arul Mahadevan received his Bachelor of Medicine and Surgery from the University of Madras (Chennai) in 1987 and received his Master of Surgery in Orthopedics from the University of Bombay in 1991. After being awarded Fellowships of the Royal Colleges of Surgeons of Edinburgh and Glasgow, United Kingdom, Dr. Mahadevan moved to the United States to practice medicine.

His interest in cancer care led him to complete residency in radiation oncology at Northwestern University, where he served as chief resident. He has completed advanced fellowship training in brachytherapy at Beth Israel Medical Center in New York and a prostate cancer brachytherapy fellowship at the Seattle Prostate Institute before joining the Cleveland Clinic as an Assistant Professor in Radiation Oncology in 2002.

While at the Cleveland Clinic, Dr. Mahadevan specialized in treating genitourinary malignancies including prostate brachytherapy and image guided radiation therapy (IGRT) and published extensively. He was also the director of clinical research at the Cleveland Clinic Cancer Center. He has an active leadership role in national cancer trials and served as Co-Director of the first International Symposium on Stereotactic Body Radiation Therapy and Stereotactic Radiosurgery.

Since joining Radiation Oncology Associates in 2008, Dr. Mahadevan has further helped us make new radiation technologies available usually only available at major academic centers. He continues to remain active in clinical trials with RTOG and serves on the Government Relations Committee and Education Committee for the American Society of Radiation Oncology. He is also the Medical Director of the Radiation Therapy Training Program of the New Hampshire Technical Institute.